Study of Orally Administered AG-221 in Subjects With Advanced Solid Tu

Discussion Board › Forums › Clinical Trials › Study of Orally Administered AG-221 in Subjects With Advanced Solid Tu

Viewing 1 post (of 1 total)
  • Author
    Posts
  • October 29, 2014 at 6:43 pm #10696
    gavin
    Moderator

    Study of Orally Administered AG-221 in Subjects With Advanced Solid Tumors, Including Glioma, and With Angioimmunoblastic T-cell Lymphoma, With an IDH2 Mutation

    http://clinicaltrials.gov/ct2/show/NCT02273739

  • Author
    Posts
Viewing 1 post (of 1 total)
  • The forum ‘Clinical Trials’ is closed to new topics and replies.